8:00 am Keynote: The Next Generation of Clinical Trials: Staying Ahead of the Change
- Today’s trends and challenges in adoption
- Forecasts for the next generation of decentralised and digital clinical trials
- Opportunities for all to engage and avoid fear of being left behind

Craig Lipset
Co-Chair
Decentralised Trials and Research Alliance
8:30 am Integrated Patient Voice in Clinical Trial Design
- A key to achieving the regulatory, ethical and scientific goals of any design strategy is listening to the voice of patients
- We’ll cover trends in listening to patients, how technology is creating data-driven insights into study-specific populations, and hear the voices of patients themselves
- Join this session to hear about the evolving role of patient voice in designing clinical trials

Noah Goodson, PhD
Director, Consulting
THREAD Research
9:00 am Innovative Technologies For Forecasting Patient Recruitment and Event Counts
- Advanced technologies to maximize patient recruitment predictability at different
stages - Forecasting recruitment under different restrictions
- Optimal cost-efficient recruitment design, sites/countries selection
- Centralized statistical monitoring and detecting unusual data patterns
- Forecasting future recruitment performance
- Forecasting event counts in event driven trials (oncology, CRV)

Prof. Dr. Vladimir Anisimov
Principal Data Scientist | Data Science | Center for Design & Analysis
Amgen
9:30 am Morning Refreshments and 1-2-1 Meetings
10:00 am Taking a Patient Centric Approach in Developing a Virtual Trial For Your Study
- Explore some of the barriers and motivators for patients to participate in decentralized trials
- Understand the places you should consider getting patient input into the development process

Jen Horonjeff
Founder and CEO
Savvy Cooperative
10:30 am Approaches to Flexible Design in Decentralized Clinical trials
• DCT overview – Pfizer’s definition and our hybrid strategy
• Our 5 priority modalities
• Challenges, Strategies, what we have Learned
• Q&A

Jeremy R. Price
Director, Clinical Innovation & Strategic Partnerships
Pfizer
11:00 am Panel: How Patients Play an Important Role in Shaping Clinical Research
- Understanding the patient’s need will help develop a comprehensive trial that will benefit both sides
- Outlining your patient scope and understand their trial preference (do they want to be on site or be part of the trial at home)
- Developing patient centric applications to help them upload their progress seamlessly

TJ Sharpe
Patient #1, Blogger and Cancer AdvocateJen Horonjeff, CEO
Savvy Cooperative

Jen Horonjeff
Founder and CEO
Savvy Cooperative

Jennifer McNary
Patient Advocate
11:30 am Lunch and 1-2-1 Meetings
10:00 am Panel: Considerations Needed When Collaborating With CRO’s on Virtual Trials
- Working on your relationship with your CRO so that concerns can be raised before they have a chance to negatively impact your trial
- Best practices in re-monitoring your data if needed in order to ensure that the data you have received is reliable
- The steps we should all be taking to cover ourselves in case the worst should happen and we are let down by our CRO

Aman Thukral
Head of Digital Operations and eCOA
AbbVie

Katie Madden
Manager, Digital and Process Optimization, Digital, Analytics & Performance Development – R&D
GSK
12:30 pm Q&A with Expert Speaker: Addressing the Barriers of DEI in Clinical Trials
- Enhancing communication to Build workflows into patient visits so potential participants know there are trials available to them
- Building trust to understand the participants background, which helps develop an effective trial
- Taking extra time to review and understand where an individual’s biases may have impacted the design can greatly minimize the risk of creating a non-inclusive trial

Melaina Boyce
Director, Clinical Innovation
EMD Serono the Healthcare business of Merck KGaA, Darmstadt, Germany

Mohamed Abukar
Senior Analyst
GlobalData
1:00 pm The Shifting Landscape of Virtual Trials
- The usage data of virtual trial elements pre and post pandemic
- Identify how the utilization has evolved using various trial related metrics
- Looking to the future to analyze which elements will maintain, reduce or increase uptake in the coming years

Mohamed Abukar
Senior Analyst
GlobalData
1:30 pm End of Event
Sponsorship opportunities
To enquire about sponsorship opportunities for the conference, please contact:
Paul Adams
pauladams@arena-international.com
+44 (0)20 7936 6948
Speaker Opportunities
We identify and invite individuals we believe to be the best speakers in the market, if you think you can make a difference to the quality of our events please contact the programme director of the event:
Edwin Boadu
Conference Producer
Arena International
T: 02079472935
E: edwin.boadu@arena-international.com